Pertzye and Sinusitis - acute - a phase IV clinical study of FDA data

Summary:

Sinusitis - acute is reported as a side effect among people who take Pertzye (pancrelipase (amylase;lipase;protease)), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Pulmozyme, and have Cystic fibrosis.

The phase IV clinical study analyzes which people have Sinusitis - acute when taking Pertzye. It is created by eHealthMe based on reports of 734 people who have side effects when taking Pertzye from the FDA, and is updated regularly.

What is Pertzye?

Pertzye has active ingredients of pancrelipase (amylase;lipase;protease). eHealthMe is studying from 734 Pertzye users. Check the latest studies of Pertzye.

What is Sinusitis - acute?

Sinusitis - acute is found to be associated with 3,437 drugs and 2,773 conditions by eHealthMe. Check the latest studies of Sinusitis - acute.

On Jul, 08, 2026

734 people reported to have side effects when taking Pertzye.
Among them, 14 people (1.91%) have Sinusitis - acute.

Among these 14 people:

How long have people been on Pertzye when they have Sinusitis - acute? *

What is the gender of people who have Sinusitis - acute when taking Pertzye? *

female: 57.14 %
male: 42.86 %

What is the age of people who have Sinusitis - acute when taking Pertzye? *

What are other drugs people take besides Pertzye? *

What are other side effects people have besides Sinusitis - acute? *

Flatulence (flatus expelled through the anus): 3 people, 21.43%
Muscle Spasms (muscle contraction): 2 people, 14.29%
Abdominal Distension: 2 people, 14.29%
Abdominal Pain: 2 people, 14.29%
Balance Disorder: 2 people, 14.29%
Vertigo Positional: 2 people, 14.29%
Otitis (ear infection): 1 person, 7.14%
Nausea And Vomiting: 1 person, 7.14%
Sinus Disorder (disease of sinus): 1 person, 7.14%
Respiratory Disorder (respiratory disease): 1 person, 7.14%

What are the existing conditions these people have? *

Cystic Fibrosis (disease of the secretary glands): 10 people, 71.43%
Carcinoid Syndrome (syndrome includes flushing and diarrhoea, and, less frequently, heart failure and bronchoconstriction): 4 people, 28.57%
Wheezing (a high-pitched whistling sound made while you breath): 1 person, 7.14%
Pain: 1 person, 7.14%
Cough: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Pertzye and have Sinusitis - acute?

- Check whether Sinusitis - acute is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Pertzye:

Pertzye (734 reports)

Sinusitis - acute treatments and more:

Sinusitis - acute (153,485 reports)

How severe was Sinusitis - acute and when was it recovered:

Sinusitis - acute in Pertzye

Expand to all the drugs that have ingredients of pancrelipase (amylase;lipase;protease):

Sinusitis - acute and drugs with ingredients of pancrelipase (amylase;lipase;protease) (435 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Pertzye:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Sinusitis - acute:

Sinusitis - acute (3,437 drugs)

Browse all the conditions that are associated with Sinusitis - acute:

Sinusitis - acute (2,773 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on pancrelipase (amylase;lipase;protease) (the active ingredients of Pertzye) and Pertzye (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.